Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination

Table 1

Muscle and kidney function biomarkers during the admission. The combination of atorvastatin and fusidic acid stopped at day 6 since admission.

Days; (according to admission)	Creatinine kinase; (normal 40–280 U/L)	Myoglobulin; (normal 24–77 ng/L)	Creatinine; (normal 60–105 micromole/L)	Urea; (normal 3.5–8.1 mmol/L)
1	—	—	128	16.8
2	—	—	—	—
3	—	—	—	—
4	—	—	119	—
5	10865	—	108	—
6	10750	—	92	—
7	22520	—	134	—
8	35080	—	134	—
9	>20000	26300	100	22.2
10	8070	7110	85	21.8
11	3350	2590	74	19.5
12	1740	—	74	17.0
13	755	—	62	13.3
14	314	—	70	10.4
15	197	143	68	8.1
16	149	89	81	7.7
17	112	94	79	8.0
22	389	—	81	8.0
26	72	—	85	—
29	71	—	85	—